A single-center, retrospective, matched cohort study evaluating safety and effectiveness of apixaban versus warfarin in patients with severe renal impairment.

Trial Profile

A single-center, retrospective, matched cohort study evaluating safety and effectiveness of apixaban versus warfarin in patients with severe renal impairment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs Apixaban (Primary) ; Warfarin
  • Indications Blood coagulation disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Feb 2017 New trial record
    • 24 Jan 2017 Primary endpoint (Major bleeding) has not been met, as per an article published in the Pharmacotherapy.
    • 24 Jan 2017 Results published in the Pharmacotherapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top